These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7171336)

  • 21. Glutamine estimation in cerebrospinal fluid in cases of liver cirrhosis and hepatic coma.
    GILON E; SZEINBERG A; TAUMAN G; BODONYI E
    J Lab Clin Med; 1959 May; 53(5):714-9. PubMed ID: 13654912
    [No Abstract]   [Full Text] [Related]  

  • 22. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic significance of subclinical hepatic encephalopathy.
    Hartmann IJ; Groeneweg M; Quero JC; Beijeman SJ; de Man RA; Hop WC; Schalm SW
    Am J Gastroenterol; 2000 Aug; 95(8):2029-34. PubMed ID: 10950053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hepatic encephalopathies].
    Gerok W
    Infusionsther Klin Ernahr; 1987 Oct; 14 Suppl 5():43-9. PubMed ID: 2893770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperammonaemia without portal systemic shunting does not resemble hepatic encephalopathy.
    Chamuleau RA; Vogels BA
    Adv Exp Med Biol; 1997; 420():173-83. PubMed ID: 9286433
    [No Abstract]   [Full Text] [Related]  

  • 26. Glutamine, myo-inositol, and organic brain osmolytes after portocaval anastomosis in the rat: implications for ammonia-induced brain edema.
    Cordoba J; Gottstein J; Blei AT
    Hepatology; 1996 Oct; 24(4):919-23. PubMed ID: 8855198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effect of L-carnitine in ammonia-precipitated encephalopathy in the portacaval shunted rat.
    Therrien G; Rose C; Butterworth J; Butterworth RF
    Hepatology; 1997 Mar; 25(3):551-6. PubMed ID: 9049197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A method for the determination of glutamine in cerebrospinal fluid and the results in hepatic coma.
    WHITEHEAD TP; WHITTAKER SR
    J Clin Pathol; 1955 Feb; 8(1):81-4. PubMed ID: 14354038
    [No Abstract]   [Full Text] [Related]  

  • 29. MR and 1H MR spectroscopy of the brain in patients with liver cirrhosis and early stages of hepatic encephalopathy.
    Tarasów E; Panasiuk A; Siergiejczyk L; Orzechowska-Bobkiewicz A; Lewszuk A; Walecki J; Prokopowicz D
    Hepatogastroenterology; 2003; 50(54):2149-53. PubMed ID: 14696484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperammonemic encephalopathy due to essential amino acid hyperalimentation.
    Grazer RE; Sutton JM; Friedstrom S; McBarron FD
    Arch Intern Med; 1984 Nov; 144(11):2278-9. PubMed ID: 6437358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy.
    Romero-Gómez M; Boza F; García-Valdecasas MS; García E; Aguilar-Reina J
    Am J Gastroenterol; 2001 Sep; 96(9):2718-23. PubMed ID: 11569701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of hepatic coma with L-dopa. Preliminary results].
    Sarrazin A; Emerit J; Olivier L; Rebelo F; Bousquet O
    Presse Med (1893); 1971 Nov; 79(49):2226-7. PubMed ID: 5156758
    [No Abstract]   [Full Text] [Related]  

  • 33. Proton magnetic resonance spectroscopy (1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve.
    Lee JH; Seo DW; Lee YS; Kim ST; Mun CW; Lim TH; Min YI; Suh DJ
    Am J Gastroenterol; 1999 Aug; 94(8):2206-13. PubMed ID: 10445551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha-ketoglutaramate, a neurotoxic agent in hepatic coma.
    Vergara F; Duffy TE; Plum F
    Trans Assoc Am Physicians; 1973; 86():255-63. PubMed ID: 4788800
    [No Abstract]   [Full Text] [Related]  

  • 35. [Portal-systemic encephalopathy or shunt encephalopathy].
    Takeuchi H
    Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):129-32. PubMed ID: 11031913
    [No Abstract]   [Full Text] [Related]  

  • 36. Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging.
    Geissler A; Lock G; Fründ R; Held P; Hollerbach S; Andus T; Schölmerich J; Feuerbach S; Holstege A
    Hepatology; 1997 Jan; 25(1):48-54. PubMed ID: 8985263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic encephalopathy EEG and octopamine.
    Bucci L; Chiaverelli R
    J Clin Psychiatry; 1980 May; 41(5):175-7. PubMed ID: 6768720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenesis of hepatic coma.
    Zieve L; Nicoloff DM
    Annu Rev Med; 1975; 26():143-57. PubMed ID: 167647
    [No Abstract]   [Full Text] [Related]  

  • 39. Diagnosis and treatment of hepatic encephalopathy.
    Blei AT
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Dec; 14(6):959-74. PubMed ID: 11139349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Confusion and abnormal liver enzyme levels: problems with diagnosing hepatic encephalopathy].
    Hendriks ME; van Westerloo DJ; Portegies P
    Ned Tijdschr Geneeskd; 2007 Dec; 151(49):2701-6. PubMed ID: 18225787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.